Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Medical Devices

Taiwan neurosurgery robotic surgical systems market to grow at 9% CAGR through 2036, forecasts GlobalData

Taiwan’s neurosurgery robotic surgical systems market is gradually gaining ground, driven by the growing demand for minimally invasive procedures, an ageing population, and rising chronic health conditions. Owing to these factors, the neurosurgery robotic surgical systems market is set to expand at a compound annual growth rate (CAGR) of 9% through 2036, forecasts GlobalData, a […]
Read more

European medtech companies to face uphill battle to maintain market shares from China’s import restrictions, says GlobalData

European medical device manufacturers are facing fresh pressure after China introduced new procurement limits on foreign-made equipment this month. The policy bars state hospitals and institutions from buying European devices in contracts exceeding 45 million yuan (roughly $6.3 million). This price range covers many of the most advanced tools used in hospitals. Medical giants such […]
Read more

Australia eyes medtech leadership with bold investment drive, says GlobalData

Australia’s bold $65.5 million investment in biomedical and medical technologies (medtech) marks a strategic shift toward healthcare innovation and self-reliance. By boosting domestic R&D and manufacturing, the country aims to improve patient outcomes and reduce import dependency. With additional funding for chronic disease solutions, Australia is positioning itself as a hub for next-generation medical device […]
Read more

US tariff expansion on Chinese medical devices could significantly disrupt global supply chain, says GlobalData

Leading US medtech firms have mobilized on Capitol Hill to oppose proposed Section 301 tariffs on Chinese medical devices. Industry representatives, including AdvaMed, are urging lawmakers and trade officials to reconsider the tariff expansion amid growing concerns over its economic and clinical impact. The tariffs could significantly disrupt global supply chains and inflate healthcare costs, […]
Read more

Transcatheter mitral valve repair market in India to grow at 17% CAGR through 2036, forecasts GlobalData

Transcatheter mitral valve repair (TMVR) is among a rising class of catheter-based therapies for heart defects and valve disorders, providing a critical treatment option for patients with severe mitral regurgitation associated with obesity, hypertension, and type 2 diabetes who are not suitable candidates for surgery. The TMVR market in India is projected to grow at […]
Read more

New CGM-enabled insulin delivery systems address demand for automated diabetes care, says GlobalData

With around 2 million Americans living with type 1 diabetes, and an increasing number of insulin-requiring type 2 cases, the US healthcare system is experiencing growing demand for simplified, automated diabetes care. The integration of Abbott Laboratories’ FreeStyle Libre 3 Plus continuous glucose monitor (CGM) with the Tandem t:slim X2 insulin pump system marks a […]
Read more

Japan cardiac marker tests market to reach $19 million by 2036, forecasts GlobalData

The increasing global burden of cardiovascular diseases (CVD), driven by lifestyle-related risk factors and limited access to early diagnostics, has accelerated the demand for advanced, data-driven medical solutions. Against this backdrop, Japan’s cardiac marker tests market value is forecast to reach $19 million by 2036, according to GlobalData, a leading data and analytics company. GlobalData’s […]
Read more

GeneCentric’s funding highlights growing investor interest in RNA-driven diagnostics in precision oncology, says GlobalData

GeneCentric Therapeutics has recently secured $8 million in new funding to advance its RNA-based liquid biopsy platform. The financing will support the development and commercialization of GeneCentric’s platform, which enables non-invasive tumor profiling to guide treatment decisions and monitor disease progression. The funding reflects the growing investor enthusiasm for RNA-driven diagnostics in precision oncology, according […]
Read more

Japan diagnostic imaging market poised for 2% CAGR through 2034, forecasts GlobalData

Japan’s diagnostic imaging sector is undergoing significant transformation, with cutting-edge technologies that are re-defining capabilities across techniques such as CT, MRI, ultrasound, and breast imaging. Against this backdrop, the country’s diagnostic imaging market is projected to expand at a compound annual growth rate (CAGR) of 2% through 2034, forecasts GlobalData, a leading data and analytics […]
Read more

US HPV testing market shielded from tariffs but export risks for domestic makers remain, reveals GlobalData

The US human papillomavirus (HPV) testing market will remain unaffected by the Trump Administration’s tariffs, as the leading tests—Roche’s cobas and Hologic’s Aptima Panther—are entirely manufactured within the country. With 94.6% of HPV tests produced within the country, the risk of cost increases or supply chain disruptions is minimal. However, export challenges may arise for […]
Read more

Abbott and Medtronic best positioned manufacturers in US neurology market, says GlobalData

As US tariff policies evolve in 2025, neurology device manufacturers face rising cost pressures and growing uncertainty over production strategy. However, Abbott and Medtronic are best positioned among top competitors, with majority of their 510(k)-approved neurology devices manufactured exclusively in the US, respectively, according to the MedSource Database of GlobalData, a leading data and analytics […]
Read more

US cardiovascular device market under threat from tariffs, says GlobalData

US medical device companies continue to face uncertainty and instability as President Donald Trump’s tariffs continue to disrupt the market. Major manufacturers are currently most concerned with supply chain interruptions and cost increases, leading to constant adjustments of company forecasts. Cardiovascular devices are especially vulnerable to the impacts of tariffs, as many of these devices […]
Read more

GlobalData highlights impact of US tariffs on medical robotics industry

The US government’s imposition of new tariffs in 2025 marks a significant shift in trade policy that has wide-reaching implications across multiple sectors, including healthcare. Among the most affected segments is the medical robotics industry, a high-growth field that blends precision engineering, artificial intelligence (AI), and life-saving applications in surgery and diagnostics. While tariffs are […]
Read more

Pulsed field ablation devices face growth challenges as US tariffs disrupt cardiovascular market, says GlobalData

The US cardiovascular devices market is facing growing challenges as President Trump’s tariffs disrupt global supply chains and worsen international relations. Particularly, pulsed field ablation (PFA) devices, often manufactured abroad for cost, efficiency, and material access, are now subject to higher tariffs. This disruption could slow the significant growth seen in the sector in recent […]
Read more
1 … 3 4 5 6 7 … 50